'US FDA clears IND filed by the University of Rochester (NY) for a phase 1c/2a clinical trial of PXS‐5505 in hepatocellular
carcinoma (HCC) patients. PXS‐5505 to be added to current chemotherapy standard of care as first line therapy in newly
diagnosed patients with unresectable HCC carcinoma'
'unresectable' add that to my vocab
Hold on tight!
Its going to be one interesting year...most impressive prospective Biotech by far
Commercially minded Gary! Shareholders are fortunate to have him!
Practical achievable commercial targets! Well done!
Speed and reach of network...incredible!
Impressive pipeline
Drug discovery team....WORLD CLASS!
- Forums
- ASX - By Stock
- SNT
- Ann: Presentation - quarterly investor update
Ann: Presentation - quarterly investor update, page-2
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.53M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.6¢ | $60.95K | 1.297M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 62987 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 62460 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 62987 | 0.046 |
2 | 244444 | 0.045 |
5 | 572000 | 0.044 |
3 | 239999 | 0.043 |
5 | 112500 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 62460 | 1 |
0.049 | 159535 | 2 |
0.050 | 83104 | 2 |
0.052 | 107600 | 2 |
0.054 | 50000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |